NCT04339634View on ClinicalTrials.gov

Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy

CompletedOBSERVATIONAL

Enrollment

12,873

Participants

Timeline

Start Date

April 2, 2020

Primary Completion Date

January 30, 2023

Study Completion Date

January 30, 2023

Conditions

COVIDDrug EffectDrug InteractionAdverse Drug Event

Interventions

OTHER

Simulation of Repurposed Drugs for COVID-19

This study is a simulation of adding repurposed drugs for COVID-19. We are using drug claims, and will not intervene with patient care.

Trial Locations (1)

32827

Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando

All Listed Sponsors

lead

Tabula Rasa HealthCare

INDUSTRY

NCT04339634 - Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy | Biotech Hunter | Biotech Hunter